Cargando…

Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis

BACKGROUND: Meta-analyses indicate superiority of antipsychotic maintenance treatment over discontinuation within up to 24 months after treatment initiation for patients with schizophrenia-spectrum disorders. In terms of functional recovery, long-term trials show improved functioning after discontin...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlier, Björn, Buck, Laura, Müller, Rebecca, Lincoln, Tania M., Bott, Antonia, Pillny, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663674/
https://www.ncbi.nlm.nih.gov/pubmed/38021372
http://dx.doi.org/10.1016/j.eclinm.2023.102291
_version_ 1785138451421593600
author Schlier, Björn
Buck, Laura
Müller, Rebecca
Lincoln, Tania M.
Bott, Antonia
Pillny, Matthias
author_facet Schlier, Björn
Buck, Laura
Müller, Rebecca
Lincoln, Tania M.
Bott, Antonia
Pillny, Matthias
author_sort Schlier, Björn
collection PubMed
description BACKGROUND: Meta-analyses indicate superiority of antipsychotic maintenance treatment over discontinuation within up to 24 months after treatment initiation for patients with schizophrenia-spectrum disorders. In terms of functional recovery, long-term trials show improved functioning after discontinuation, suggesting a time-dependent effect of antipsychotic maintenance. However, these trials were not included in previous meta-analyses. We therefore investigated whether the effect of antipsychotic maintenance treatment vs. discontinuation on social functioning and quality of life varies by trial length. METHODS: The study was preregistered with PROSPERO (CRD42021248933). PubMed, PsycINFO, Web of Science, Embase and trial registers were systematically searched on 8th November 2021 and updated on 25th June, 2023 and 10th August, 2023 for studies that compared antipsychotic maintenance to discontinuation and reported data on social functioning or subjective quality of life in patients with schizophrenia-spectrum disorders. Risk of bias was assessed with the RoB 2, the ROBINS-I and the RoB-ME tools. Quality of evidence was rated using the Grading of Recommendations Assessment, Development, and Evaluation approach. FINDINGS. We included k = 35 studies (N = 5924) with follow-ups between one month and 15 years. Overall, maintenance and discontinuation did not differ on social functioning (k = 32; n = 5330; SMD = 0.204; p = 0.65; 95% CI [−0.69, 1.10]) or quality of life (k = 10; n = 943; SMD = −0.004; p = 0.97; 95% CI [−0.22, 0.21]), whilst subgroup analyses of middle- (2–5 years; k = 7; n = 1032; SMD = 0.68; 95% CI [0.06, 1.28]) and long-term follow-ups (>5 years; k = 2; n = 356; SMD = 1.04; 95% CI [0.82, 1.27]) significantly favoured discontinuation. However, the quality of evidence was rated as very low. INTERPRETATION: Although our findings suggest a time-dependent decrease in the effect of maintenance treatment on social functioning, interpretation of these findings is limited by the serious risk of bias in middle- and long-term trials. Therefore, any conclusions regarding the long-term benefits of antipsychotic treatment or discontinuation for functional recovery are premature and more high-quality trials tailored to comparing state of the art maintenance treatment vs. discontinuation are needed. FUNDING: None.
format Online
Article
Text
id pubmed-10663674
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106636742023-11-09 Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis Schlier, Björn Buck, Laura Müller, Rebecca Lincoln, Tania M. Bott, Antonia Pillny, Matthias eClinicalMedicine Articles BACKGROUND: Meta-analyses indicate superiority of antipsychotic maintenance treatment over discontinuation within up to 24 months after treatment initiation for patients with schizophrenia-spectrum disorders. In terms of functional recovery, long-term trials show improved functioning after discontinuation, suggesting a time-dependent effect of antipsychotic maintenance. However, these trials were not included in previous meta-analyses. We therefore investigated whether the effect of antipsychotic maintenance treatment vs. discontinuation on social functioning and quality of life varies by trial length. METHODS: The study was preregistered with PROSPERO (CRD42021248933). PubMed, PsycINFO, Web of Science, Embase and trial registers were systematically searched on 8th November 2021 and updated on 25th June, 2023 and 10th August, 2023 for studies that compared antipsychotic maintenance to discontinuation and reported data on social functioning or subjective quality of life in patients with schizophrenia-spectrum disorders. Risk of bias was assessed with the RoB 2, the ROBINS-I and the RoB-ME tools. Quality of evidence was rated using the Grading of Recommendations Assessment, Development, and Evaluation approach. FINDINGS. We included k = 35 studies (N = 5924) with follow-ups between one month and 15 years. Overall, maintenance and discontinuation did not differ on social functioning (k = 32; n = 5330; SMD = 0.204; p = 0.65; 95% CI [−0.69, 1.10]) or quality of life (k = 10; n = 943; SMD = −0.004; p = 0.97; 95% CI [−0.22, 0.21]), whilst subgroup analyses of middle- (2–5 years; k = 7; n = 1032; SMD = 0.68; 95% CI [0.06, 1.28]) and long-term follow-ups (>5 years; k = 2; n = 356; SMD = 1.04; 95% CI [0.82, 1.27]) significantly favoured discontinuation. However, the quality of evidence was rated as very low. INTERPRETATION: Although our findings suggest a time-dependent decrease in the effect of maintenance treatment on social functioning, interpretation of these findings is limited by the serious risk of bias in middle- and long-term trials. Therefore, any conclusions regarding the long-term benefits of antipsychotic treatment or discontinuation for functional recovery are premature and more high-quality trials tailored to comparing state of the art maintenance treatment vs. discontinuation are needed. FUNDING: None. Elsevier 2023-11-09 /pmc/articles/PMC10663674/ /pubmed/38021372 http://dx.doi.org/10.1016/j.eclinm.2023.102291 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Schlier, Björn
Buck, Laura
Müller, Rebecca
Lincoln, Tania M.
Bott, Antonia
Pillny, Matthias
Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis
title Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis
title_full Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis
title_fullStr Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis
title_full_unstemmed Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis
title_short Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis
title_sort time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life–a multilevel meta-analysis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663674/
https://www.ncbi.nlm.nih.gov/pubmed/38021372
http://dx.doi.org/10.1016/j.eclinm.2023.102291
work_keys_str_mv AT schlierbjorn timedependenteffectofantipsychoticdiscontinuationanddosereductiononsocialfunctioningandsubjectivequalityoflifeamultilevelmetaanalysis
AT bucklaura timedependenteffectofantipsychoticdiscontinuationanddosereductiononsocialfunctioningandsubjectivequalityoflifeamultilevelmetaanalysis
AT mullerrebecca timedependenteffectofantipsychoticdiscontinuationanddosereductiononsocialfunctioningandsubjectivequalityoflifeamultilevelmetaanalysis
AT lincolntaniam timedependenteffectofantipsychoticdiscontinuationanddosereductiononsocialfunctioningandsubjectivequalityoflifeamultilevelmetaanalysis
AT bottantonia timedependenteffectofantipsychoticdiscontinuationanddosereductiononsocialfunctioningandsubjectivequalityoflifeamultilevelmetaanalysis
AT pillnymatthias timedependenteffectofantipsychoticdiscontinuationanddosereductiononsocialfunctioningandsubjectivequalityoflifeamultilevelmetaanalysis